Alkermes (ALKS) Change in Inventory (2016 - 2026)
Alkermes (ALKS) posted quarterly Change in Inventory of -$7.4 million for Q2 2026, down 189.74% year-over-year from $8.3 million in Q2 2025, and down 215.78% quarter-over-quarter from $6.4 million in Q1 2026.
Alkermes (ALKS) Change in Inventory (2016 - 2026) Analysis & Trends
Alkermes (ALKS) has reported Change in Inventory for 11 consecutive years, with -$7.4 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Change in Inventory fell 189.74% year-over-year to -$7.4 million; the TTM figure through Jun 2026 stood at $3.0 million (up 216.16% YoY), while the FY2025 annual figure was $14.1 million, up 554.9% from the prior year.
- Change in Inventory slipped to -$7.4 million in Q2 2026 per ALKS's latest filing, from $6.4 million in the prior quarter.
- Across five years, Change in Inventory topped out at $15.4 million in Q4 2022 and bottomed at -$9.1 million in Q4 2024.
- Historically, Change in Inventory has averaged $2.4 million across 5 years, with a median of $2.5 million in 2023.
- Annual changes were most pronounced in 2023 — Change in Inventory jumped 1607.75% — and 2024, when it sank 216.74%.
- Alkermes' Change in Inventory stood at $15.4 million in 2022, then slumped by 146.53% to -$7.2 million in 2023, then dropped by 27.79% to -$9.1 million in 2024, then soared by 153.19% to $4.9 million in 2025, then tumbled by 253.01% to -$7.4 million in 2026.
- Business Quant data shows ALKS's Change in Inventory at -$7.4 million in Q2 2026, $6.4 million in Q1 2026, and $4.9 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.76 Bn | 2.15 Bn | -59.00 Mn |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | 23.00 Mn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.98 Bn | 5.10 Bn | -209.58 Mn |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn | 17.70 Mn |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn | 99.50 Mn |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn | 6.50 Mn |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Alkermes | 8.20 Bn | 7.55 Bn | 397.90 Mn | -7.44 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -7.44 Mn |
| Jun 30, 2026 | -7.44 Mn |
| Mar 31, 2026 | 6.43 Mn |
| Mar 31, 2026 | 6.43 Mn |
| Dec 31, 2025 | 4.86 Mn |
| Dec 31, 2025 | 4.86 Mn |
| Sep 30, 2025 | -845,000.00 |
| Sep 30, 2025 | -845,000.00 |
| Jun 30, 2025 | 8.29 Mn |
| Jun 30, 2025 | 8.29 Mn |
| Mar 31, 2025 | 1.75 Mn |
| Mar 31, 2025 | 1.75 Mn |
| Dec 31, 2024 | -9.14 Mn |
| Dec 31, 2024 | -9.14 Mn |
| Sep 30, 2024 | -3.49 Mn |
| Sep 30, 2024 | -3.49 Mn |
| Jun 30, 2024 | -3.10 Mn |
| Jun 30, 2024 | -3.10 Mn |
| Mar 31, 2024 | 12.64 Mn |
| Mar 31, 2024 | 12.64 Mn |